DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Trafermin is an investigational drug.
There have been 6 clinical trials for Trafermin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2008.
The most common disease conditions in clinical trials are Periodontitis, Diabetic Foot, and Ulcer. The leading clinical trial sponsors are Kaken Pharmaceutical, Olympus Biotech Corporation, and [disabled in preview].
Recent Clinical Trials for Trafermin
|The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study||Olympus Biotech Corporation||Phase 3|
|The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study||Olympus Biotech Corporation||Phase 3|
|A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)||Kaken Pharmaceutical||Phase 3|